Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis
Author
Abstract
Suggested Citation
DOI: 10.1007/s10198-006-0365-y
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Kobelt, Gisela & Lindgren, Peter & Parkin, David & Francis, David A. & Johnson, Michael & Bates, David & Jönsson, Bengt, 2000. "Costs and Quality of Life in Multiple Sclerosis. A Cross-Sectional Observational Study in the UK," SSE/EFI Working Paper Series in Economics and Finance 398, Stockholm School of Economics.
- Koopmanschap, Marc A. & Rutten, Frans F. H. & van Ineveld, B. Martin & van Roijen, Leona, 1995. "The friction cost method for measuring indirect costs of disease," Journal of Health Economics, Elsevier, vol. 14(2), pages 171-189, June.
- Torrance, George W., 1986. "Measurement of health state utilities for economic appraisal : A review," Journal of Health Economics, Elsevier, vol. 5(1), pages 1-30, March.
- Henriksson, Freddie & Fredrikson, Sten & Jönsson, Bengt, 2000. "Costs, Quality of Life and Disease Severity in Multiple Sclerosis - A Population-Based Cross-Sectional Study in Sweden," SSE/EFI Working Paper Series in Economics and Finance 361, Stockholm School of Economics.
- Kobelt, Gisela & Lindgren, Peter & Smala, Antje & Jönsson, Bengt, 2000. "Costs and Quality of Life in Multiple Sclerosis. A Cross-Sectional Observational Study in Germany," SSE/EFI Working Paper Series in Economics and Finance 399, Stockholm School of Economics.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- B. Svendsen & N. Grytten & L. Bø & H. Aarseth & T. Smedal & K-M. Myhr, 2018. "The economic impact of multiple sclerosis to the patients and their families in Norway," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(9), pages 1243-1257, December.
- Jonathan Alsop & Jennie Medin & Christian Cornelissen & Stefan Viktor Vormfelde & Tjalf Ziemssen, 2017. "Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-15, May.
- B. Svendsen & K.-M. Myhr & H. Nyland & J. Aarseth, 2012. "The cost of multiple sclerosis in Norway," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(1), pages 81-91, February.
- Oliver Findling & Magdalena Baltisberger & Simon Jung & Christian P Kamm & Heinrich P Mattle & Johann Sellner, 2015. "Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis—A Cohort Study," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-9, April.
- Kobelt, G., 2013. "Health Economics: An Introduction to Economic Evaluation," Monographs, Office of Health Economics, number 000004.
- A. J. Hawton & C. Green, 2016. "Multiple sclerosis: relapses, resource use, and costs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(7), pages 875-884, September.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Gisela Kobelt & J. Berg & P. Lindgren & G. Izquierdo & O. Sánchez-Soliño & J. Pérez-Miranda & M. Casado, 2006. "Costs and quality of life of multiple sclerosis in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(2), pages 65-74, July.
- Paul Hanly & Rebecca Maguire & Frances Drummond & Linda Sharp, 2019. "Variation in the methodological approach to productivity cost valuation: the case of prostate cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1399-1408, December.
- Kobelt, Gisela & Berg, Jenny & Atherley, Debbie & Hadjimichael, Olympia & Jönsson, Bengt, 2005. "Costs and Quality of Life in Multiple Sclerosis A Cross-Sectional Study in the USA," SSE/EFI Working Paper Series in Economics and Finance 594, Stockholm School of Economics.
- Annie Hawton & James Shearer & Elizabeth Goodwin & Colin Green, 2013. "Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis," Applied Health Economics and Health Policy, Springer, vol. 11(4), pages 331-341, August.
- Jenny Berg & P. Lindgren & Sten Fredrikson & Gisela Kobelt, 2006. "Costs and quality of life of multiple sclerosis in Sweden," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(2), pages 75-85, July.
- Gisela Kobelt & Jenny Berg & Peter Lindgren & M. Battaglia & C. Lucioni & A. Uccelli, 2006. "Costs and quality of life of multiple sclerosis in Italy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(2), pages 45-54, July.
- Green, Gill & Todd, Jennifer & Pevalin, David, 2007. "Biographical disruption associated with multiple sclerosis: Using propensity scoring to assess the impact," Social Science & Medicine, Elsevier, vol. 65(3), pages 524-535, August.
- Brouwer, Werner B. F. & Koopmanschap, Marc A., 2000. "On the economic foundations of CEA. Ladies and gentlemen, take your positions!," Journal of Health Economics, Elsevier, vol. 19(4), pages 439-459, July.
- Kristina Burström & Magnus Johannesson & Finn Diderichsen, 2003. "The value of the change in health in Sweden 1980/81 to 1996/97," Health Economics, John Wiley & Sons, Ltd., vol. 12(8), pages 637-654, August.
- David Parkin & Nancy Devlin, 2006.
"Is there a case for using visual analogue scale valuations in cost‐utility analysis?,"
Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 653-664, July.
- Parkin, D. & Devlin, N., 2004. "Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis?," Working Papers 04/03, Department of Economics, City University London.
- Paul Clay Sorum, 1999. "Measuring Patient Preferences by Willingness to Pay to Avoid," Medical Decision Making, , vol. 19(1), pages 27-37, January.
- Bansback, Nick & Brazier, John & Tsuchiya, Aki & Anis, Aslam, 2012. "Using a discrete choice experiment to estimate health state utility values," Journal of Health Economics, Elsevier, vol. 31(1), pages 306-318.
- Iris Arends & Ute Bültmann & Willem van Rhenen & Henk Groen & Jac J L van der Klink, 2013. "Economic Evaluation of a Problem Solving Intervention to Prevent Recurrent Sickness Absence in Workers with Common Mental Disorders," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-1, August.
- Simon Wieser & Bruno Horisberger & Sara Schmidhauser & Claudia Eisenring & Urs Brügger & Andreas Ruckstuhl & Jürg Dietrich & Anne Mannion & Achim Elfering & Özgür Tamcan & Urs Müller, 2011. "Cost of low back pain in Switzerland in 2005," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 455-467, October.
- John A. Nyman, 2012. "Productivity Costs Revisited: Toward A New Us Policy," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1387-1401, December.
- Guillem López-Casasnovas & Berta Rivera, 2002. "Las políticas de equidad en salud y las relaciones entre renta y salud," Hacienda Pública Española / Review of Public Economics, IEF, vol. 161(2), pages 99-126, June.
- Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2023.
"Productivity and quality-adjusted life years: QALYs, PALYs and beyond,"
Working Papers
11-2023, Copenhagen Business School, Department of Economics.
- Kristian S. Hansen & Juan D. Moreno-Ternero & Lars P. {O}sterdal, 2024. "Productivity and quality-adjusted life years: QALYs, PALYs and beyond," Papers 2404.04121, arXiv.org.
- Hougaard, Jens Leth & Moreno-Ternero, Juan D. & Østerdal, Lars Peter, 2013.
"A new axiomatic approach to the evaluation of population health,"
Journal of Health Economics, Elsevier, vol. 32(3), pages 515-523.
- Jens Leth Hougaard & Juan D. Moreno-Ternero & Lars Peter Østerdal, 2011. "A new axiomatic approach to the evaluation of population health," Discussion Papers 11-24, University of Copenhagen. Department of Economics.
- Hougaard, Jens Leth & Moreno-Ternero, Juan D. & Østerdal, Lars Peter, 2012. "A new axiomatic approach to the evalution of population health," DaCHE discussion papers 2012:3, University of Southern Denmark, Dache - Danish Centre for Health Economics.
- Jens L. Hougaard & Juan D. Moreno-Ternero & Lars P. Osterdal, 2012. "A new axiomatic approach to the evaluation of population health," Working Papers 12.08, Universidad Pablo de Olavide, Department of Economics.
- HOUGAARD, Jean Leth & MORENO-TERNERO, Juan D. & OSTERDAL, Lars Peter, 2013. "A new axiomatic approach to the evaluation of population health," LIDAM Reprints CORE 2472, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- HOUGAARD, Jens L. & MORENO-TERNERO, Juan & OSTERDAL, Lars P., 2012. "A new axiomatic approach to the evaluation of population health," LIDAM Discussion Papers CORE 2012007, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Jens Leth Hougaard & Juan D. Moreno-Ternero & Lars Peter Østerdal, 2012. "A New Axiomatic Approach to the Evaluation of Population Health," MSAP Working Paper Series 07_2012, University of Copenhagen, Department of Food and Resource Economics.
- Garry R. Barton & Tracey H. Sach & Anthony J. Avery & Claire Jenkinson & Michael Doherty & David K. Whynes & Kenneth R. Muir, 2008. "A comparison of the performance of the EQ‐5D and SF‐6D for individuals aged ≥ 45 years," Health Economics, John Wiley & Sons, Ltd., vol. 17(7), pages 815-832, July.
- McCabe, Christopher & Brazier, John & Gilks, Peter & Tsuchiya, Aki & Roberts, Jennifer & O'Hagan, Anthony & Stevens, Katherine, 2006. "Using rank data to estimate health state utility models," Journal of Health Economics, Elsevier, vol. 25(3), pages 418-431, May.
More about this item
Keywords
Multiple sclerosis; Costs; Utilities; Cost of illness methodology;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:7:y:2006:i:2:p:5-13. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.